Medical research

New target explored for psychiatric drug development

(Medical Xpress)—In a surprising discovery, neuroscientists have found that a breakdown product of cholesterol in the brain may be a target for developing new drugs to treat schizophrenia and other mental illnesses.

Attention deficit disorders

MRI technique reveals low brain iron in ADHD patients

Magnetic resonance imaging (MRI) provides a noninvasive way to measure iron levels in the brains of people with attention deficit hyperactivity disorder (ADHD), according to a study being presented today at the annual meeting ...

Psychology & Psychiatry

Finding psychiatric drugs in the movements of mice

Developing psychiatric medications is a long and complex process. Candidate drugs are evaluated and assessed based on their effects on the behavior of animals, usually rats or mice. Each class of drugs, from antidepressants ...

Psychology & Psychiatry

Death risk higher with mental illness in drug trials

(HealthDay)—Adults with psychiatric illnesses such as schizophrenia, depression, and bipolar disorder who participate in clinical trials of psychopharmacological drugs have a higher mortality risk, in many cases by suicide, ...

Overweight & Obesity

Gene variants linked to obesity

(HealthDay)—Variants of a gene are associated with overweight and obesity in psychiatric patients taking drugs that induce weight gain, as well in the general population, according to a study published online Aug. 7 in ...

Psychology & Psychiatry

Inside the minds of murderers

(Medical Xpress)—The minds of murderers who kill impulsively, often out of rage, and those who carefully carry out premeditated crimes differ markedly both psychologically and intellectually, according to a new study by ...

page 8 from 13